ISRCTN93378085
Completed
未知
Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulation
Record Provided by the NHSTCT Register - 2007 Update - Department of Health0 sites12 target enrollmentSeptember 28, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Record Provided by the NHSTCT Register - 2007 Update - Department of Health
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adult patients with schizophrenia (ages 18\-55 years)
- •2\. Patients will be screened with the Schedule for the Assessment of Negative Symptoms (SANS) (Andreasen, 1983\). Patients with severe negative symptoms (defined by score of \= 3 in any of SANS sub\-scales) will be recruited for this study
- •3\. All participants will be assessed for intelligence using the NART (Nelson, 1991\) and handedness with Edinburgh Handedness Inventory (Oldfield, 1971\)
Exclusion Criteria
- •1\. History of neurological disorder including seizures
- •2\. General medical conditions likely to impair cortical function or haemodynamic response (hypertension or diabetes)
- •3\. Metallic implants (and other contraindications to MR procedures)
- •4\. Established drug or alcohol dependency disorders
- •5\. Estimated IQ less than 75
- •6\. Inability to give an informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Safety, Blood Levels and Effects of AUT00206SchizophreniaNCT02589262Autifony Therapeutics Limited
Completed
Phase 1
Safety, Blood Levels and Effects of AUT00201Healthy VolunteerNCT04158453Autifony Therapeutics Limited80
Completed
Phase 1
First Time in Human Study With GSK1018921SchizophreniaNCT00527020GlaxoSmithKline27
Completed
Not Applicable
Pilot study to establish the treatment of patients with frailty and sarcopenia using the device of promoting neural control of paravertebral muscleower back pain patients with frailty/sarcopenia, or having muscle weakness in their previous stageJPRN-UMIN000029803Fukuoka University Hospital8
Recruiting
Not Applicable
Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition.schizophreniasocial cognitionschizoaffective disorderMental Health - SchizophreniaACTRN12621001649808Monash University46